60. 再生不良性貧血 Aplastic anemia Clinical trials / Disease details

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05088642 (ClinicalTrials.gov)	September 28, 2020	12/10/2021	A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects	A Phase I Clinical Study Evaluating the Pharmacokinetics and Safety of Hetrombopag Olamine Tablets in Subjects With Mild Hepatic Impairment (Child-Pugh Class A), Moderate Hepatic Impairment (Child-Pugh Class B), and Normal Hepatic Function	Sever Aplastic Anaemia	Drug: Hetrombopag Olamine Tablet	Jiangsu HengRui Medicine Co., Ltd.	NULL	Completed	18 Years	65 Years	All	24	Phase 1	China
2	NCT05088174 (ClinicalTrials.gov)	September 3, 2020	12/10/2021	A Trial of Hetrombopag in Healthy Subjects	A Single-Center, Single-Arm, Open-Label, Self-Controlled, Drug-Drug Interaction Study of Hetrombopag Olamine and Ciclosporin in Healthy Subjects	Sever Aplastic Anaemia	Drug: Hetrombopag Olamine Tablet;Ciclosporin Soft Capsule	Jiangsu HengRui Medicine Co., Ltd.	NULL	Completed	18 Years	65 Years	All	26	Phase 1	China